Treatment of Severe Unconjugated Hyperbilirubinemia with Phenobarbitone in Two First-Degree Siblings with Crigler-Najjar Syndrome (CNS) Type 2: A Success Story

Background: Crigler–Najjar syndrome (CNS) type 2 is a rare autosomal recessive disorder of bilirubin conjugation caused by mutations in the UGT1A1 gene. It presents in infancy with unconjugated hyperbilirubinemia that does not respond to phototherapy but improves with phenobarbitone, which enhances...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sachin Kumar, Siddhavatam Rahul Karthik, Gandharav Pahuja, Sarthak Chakrabarti, Prateek Kumar Panda, Indar Kumar Sharawat
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Indonesian Society of Pediatric Gastroenterology, Hepatology, and Nutrition 2025-11-01
Serie:	Archives of Pediatric Gastroenterology, Hepatology, and Nutrition
Soggetti:	crigler-najjar syndrome type 2 gene therapy neonatal jaundice phenobarbitone
Accesso online:	http://www.apghn.com/index.php/journal/article/view/112
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!